 Katja Aviszus
Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocyte Subsets | 5 | 2020 | 66 | 1.030 |
Why?
| | Clonal Anergy | 5 | 2012 | 54 | 0.690 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2012 | 15 | 0.440 |
Why?
| | B-Lymphocytes | 10 | 2015 | 770 | 0.430 |
Why?
| | Antibody Formation | 2 | 2012 | 276 | 0.410 |
Why?
| | Immunologic Memory | 2 | 2007 | 313 | 0.310 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2007 | 33 | 0.310 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 5 | 2013 | 18 | 0.290 |
Why?
| | Self Tolerance | 3 | 2012 | 28 | 0.280 |
Why?
| | Immunoglobulin Variable Region | 7 | 2011 | 72 | 0.270 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2023 | 1136 | 0.240 |
Why?
| | Immunoglobulin G | 5 | 2017 | 788 | 0.240 |
Why?
| | Mice, Inbred A | 5 | 2012 | 45 | 0.240 |
Why?
| | Spleen | 3 | 2015 | 510 | 0.240 |
Why?
| | Cell Differentiation | 3 | 2007 | 1753 | 0.240 |
Why?
| | Spike Glycoprotein, Coronavirus | 2 | 2022 | 94 | 0.230 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2022 | 667 | 0.220 |
Why?
| | p-Azobenzenearsonate | 3 | 2012 | 3 | 0.200 |
Why?
| | Autoimmunity | 4 | 2013 | 831 | 0.200 |
Why?
| | Autoantigens | 3 | 2014 | 397 | 0.200 |
Why?
| | PPAR gamma | 1 | 2022 | 189 | 0.190 |
Why?
| | Adoptive Transfer | 4 | 2017 | 204 | 0.190 |
Why?
| | Mice, Transgenic | 7 | 2012 | 2025 | 0.190 |
Why?
| | Sarcoidosis, Pulmonary | 1 | 2020 | 56 | 0.180 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2020 | 83 | 0.180 |
Why?
| | Genes, Immunoglobulin | 4 | 2010 | 26 | 0.180 |
Why?
| | T-Lymphocyte Subsets | 2 | 2015 | 396 | 0.170 |
Why?
| | Berylliosis | 1 | 2020 | 183 | 0.160 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2020 | 613 | 0.160 |
Why?
| | Mice | 17 | 2017 | 15528 | 0.150 |
Why?
| | Antibodies, Antinuclear | 3 | 2014 | 55 | 0.150 |
Why?
| | Mice, Inbred C57BL | 6 | 2015 | 4914 | 0.150 |
Why?
| | Antigen-Antibody Complex | 1 | 2017 | 90 | 0.150 |
Why?
| | Receptors, Antigen, B-Cell | 3 | 2014 | 101 | 0.140 |
Why?
| | Mutation | 3 | 2022 | 3457 | 0.140 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2023 | 2062 | 0.140 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 2010 | 227 | 0.130 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 102 | 0.130 |
Why?
| | Antiviral Agents | 1 | 2021 | 654 | 0.130 |
Why?
| | Autoantibodies | 3 | 2015 | 1335 | 0.130 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2017 | 985 | 0.130 |
Why?
| | Haptens | 2 | 2007 | 22 | 0.130 |
Why?
| | Interleukin-4 | 1 | 2015 | 216 | 0.130 |
Why?
| | Mice, Knockout | 4 | 2015 | 2680 | 0.120 |
Why?
| | Fatty Acid-Binding Proteins | 2 | 2023 | 62 | 0.110 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 75 | 0.110 |
Why?
| | Animals | 17 | 2017 | 33399 | 0.110 |
Why?
| | Immunoglobulin M | 1 | 2014 | 253 | 0.110 |
Why?
| | Hybridomas | 3 | 2007 | 233 | 0.110 |
Why?
| | Hemocyanins | 3 | 2007 | 57 | 0.110 |
Why?
| | Germ-Line Mutation | 2 | 2005 | 134 | 0.100 |
Why?
| | Cells, Cultured | 3 | 2015 | 4081 | 0.100 |
Why?
| | Immunoglobulin kappa-Chains | 4 | 2011 | 18 | 0.100 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2011 | 170 | 0.090 |
Why?
| | Antibodies, Neutralizing | 2 | 2022 | 228 | 0.090 |
Why?
| | Immune Tolerance | 2 | 2017 | 334 | 0.080 |
Why?
| | Lymphocyte Activation | 2 | 2004 | 1067 | 0.080 |
Why?
| | Antibodies, Monoclonal | 3 | 2017 | 1285 | 0.080 |
Why?
| | Antibody-Producing Cells | 1 | 2007 | 29 | 0.080 |
Why?
| | Macrophages | 2 | 2022 | 1324 | 0.080 |
Why?
| | Antibody Affinity | 1 | 2007 | 55 | 0.080 |
Why?
| | Immunoglobulin Heavy Chains | 2 | 2005 | 72 | 0.080 |
Why?
| | CD40 Ligand | 1 | 2007 | 46 | 0.080 |
Why?
| | Immunization, Secondary | 1 | 2007 | 85 | 0.080 |
Why?
| | Antibody Specificity | 1 | 2007 | 184 | 0.080 |
Why?
| | Peptide Fragments | 1 | 2011 | 702 | 0.070 |
Why?
| | Immunoglobulin mu-Chains | 2 | 2003 | 7 | 0.070 |
Why?
| | Antibody Diversity | 1 | 2005 | 17 | 0.070 |
Why?
| | Gene Expression Regulation | 3 | 2022 | 2446 | 0.070 |
Why?
| | Protein Binding | 2 | 2021 | 1975 | 0.070 |
Why?
| | Transgenes | 2 | 2003 | 174 | 0.060 |
Why?
| | Interleukin-6 | 1 | 2007 | 692 | 0.060 |
Why?
| | Vaccines, Synthetic | 1 | 2022 | 128 | 0.050 |
Why?
| | Immunity, Humoral | 1 | 2022 | 117 | 0.050 |
Why?
| | Antigen-Antibody Reactions | 1 | 2021 | 51 | 0.050 |
Why?
| | Surface Plasmon Resonance | 1 | 2021 | 85 | 0.050 |
Why?
| | Receptors, Virus | 1 | 2021 | 78 | 0.050 |
Why?
| | CD11c Antigen | 1 | 2020 | 38 | 0.050 |
Why?
| | Molecular Docking Simulation | 1 | 2021 | 101 | 0.050 |
Why?
| | Ligands | 1 | 2022 | 567 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2001 | 154 | 0.050 |
Why?
| | Receptors, Fc | 1 | 2020 | 48 | 0.050 |
Why?
| | T-Box Domain Proteins | 1 | 2020 | 95 | 0.050 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2021 | 138 | 0.050 |
Why?
| | Bone Marrow Cells | 1 | 2001 | 273 | 0.040 |
Why?
| | Receptors, Complement 3d | 1 | 2020 | 129 | 0.040 |
Why?
| | Receptors, Immunologic | 1 | 2020 | 209 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 509 | 0.040 |
Why?
| | Amino Acids | 1 | 2022 | 465 | 0.040 |
Why?
| | Gene Expression | 3 | 2014 | 1492 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2020 | 367 | 0.040 |
Why?
| | Oligonucleotides | 1 | 1999 | 140 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2002 | 454 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 300 | 0.040 |
Why?
| | Humans | 9 | 2023 | 119032 | 0.040 |
Why?
| | Kinetics | 1 | 2021 | 1625 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2022 | 2661 | 0.040 |
Why?
| | Binding Sites | 1 | 2021 | 1224 | 0.040 |
Why?
| | Base Sequence | 4 | 2003 | 2160 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2014 | 1085 | 0.040 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 2017 | 56 | 0.040 |
Why?
| | Disease Progression | 1 | 2023 | 2490 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2005 | 2275 | 0.040 |
Why?
| | B-Cell Activating Factor | 1 | 2015 | 18 | 0.030 |
Why?
| | Immunophenotyping | 1 | 2017 | 278 | 0.030 |
Why?
| | Germinal Center | 1 | 2015 | 47 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2015 | 208 | 0.030 |
Why?
| | Inflammation | 2 | 2022 | 2571 | 0.030 |
Why?
| | Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2014 | 12 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2020 | 1056 | 0.030 |
Why?
| | Molecular Sequence Data | 3 | 2005 | 2873 | 0.030 |
Why?
| | Antibodies | 1 | 2015 | 392 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2014 | 405 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2020 | 3173 | 0.030 |
Why?
| | Endocytosis | 1 | 2014 | 156 | 0.030 |
Why?
| | Radiation Chimera | 1 | 2011 | 31 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 982 | 0.030 |
Why?
| | Blotting, Western | 1 | 2014 | 1195 | 0.020 |
Why?
| | Complementarity Determining Regions | 1 | 2010 | 45 | 0.020 |
Why?
| | Codon | 2 | 2002 | 89 | 0.020 |
Why?
| | Risk Factors | 1 | 2023 | 9003 | 0.020 |
Why?
| | Cell Membrane | 1 | 2014 | 710 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2010 | 276 | 0.020 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2011 | 311 | 0.020 |
Why?
| | Recombination, Genetic | 1 | 2010 | 173 | 0.020 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2011 | 355 | 0.020 |
Why?
| | Arginine | 1 | 2010 | 249 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 6562 | 0.020 |
Why?
| | snRNP Core Proteins | 1 | 2007 | 5 | 0.020 |
Why?
| | Mice, Inbred MRL lpr | 1 | 2007 | 39 | 0.020 |
Why?
| | Ribonucleoproteins, Small Nuclear | 1 | 2007 | 23 | 0.020 |
Why?
| | Calcium | 1 | 2014 | 1171 | 0.020 |
Why?
| | Receptors, IgE | 1 | 2006 | 40 | 0.020 |
Why?
| | Receptors, Complement | 1 | 2006 | 115 | 0.020 |
Why?
| | Mice, Inbred NZB | 1 | 2005 | 17 | 0.020 |
Why?
| | Young Adult | 1 | 2020 | 10799 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1774 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2006 | 446 | 0.020 |
Why?
| | Arsanilic Acid | 1 | 2003 | 1 | 0.010 |
Why?
| | Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2003 | 11 | 0.010 |
Why?
| | Immunoglobulin Class Switching | 1 | 2003 | 15 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2003 | 155 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2005 | 1206 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2003 | 336 | 0.010 |
Why?
| | Epitopes | 1 | 2004 | 443 | 0.010 |
Why?
| | Aged | 1 | 2020 | 19661 | 0.010 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2003 | 311 | 0.010 |
Why?
| | Chromatin | 1 | 2005 | 441 | 0.010 |
Why?
| | Immunity, Innate | 1 | 2007 | 745 | 0.010 |
Why?
| | Immunoglobulin delta-Chains | 1 | 2001 | 1 | 0.010 |
Why?
| | Cell Lineage | 1 | 2003 | 318 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2005 | 2073 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2002 | 381 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2010 | 3730 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2004 | 634 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 27627 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2006 | 1597 | 0.010 |
Why?
| | DNA, Single-Stranded | 1 | 2001 | 114 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2000 | 268 | 0.010 |
Why?
| | Base Composition | 1 | 1999 | 77 | 0.010 |
Why?
| | Immunoglobulin Light Chains | 1 | 1999 | 35 | 0.010 |
Why?
| | Point Mutation | 1 | 2000 | 228 | 0.010 |
Why?
| | Male | 2 | 2020 | 57818 | 0.010 |
Why?
| | DNA Primers | 1 | 2000 | 533 | 0.010 |
Why?
| | Adult | 1 | 2020 | 31525 | 0.010 |
Why?
| | RNA Splicing | 1 | 2000 | 243 | 0.010 |
Why?
| | DNA Repair | 1 | 2000 | 198 | 0.010 |
Why?
| | Female | 2 | 2020 | 61588 | 0.010 |
Why?
| | Alleles | 1 | 2001 | 832 | 0.010 |
Why?
| | Kidney | 1 | 2004 | 1357 | 0.010 |
Why?
| | Nucleic Acid Conformation | 1 | 1999 | 670 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2000 | 1323 | 0.010 |
Why?
| | RNA | 1 | 2000 | 833 | 0.010 |
Why?
| | Biomarkers | 1 | 2001 | 3590 | 0.010 |
Why?
|
|
Aviszus's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|